ACTIVE

CORUM

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

11,1 k €

-64.5% YoY

Gross margin

96,6 k €

-24.7% YoY

Equity

529 k €

+2.1% YoY

Workforce

1,3 ETP

+18.2% YoY

What does CORUM do?

CORUM is a Public limited company incorporated in 1990. Its registered office is in Gent. It employs on average 1,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0440.033.372

Incorporation

09/02/1990

Legal form

Public limited company

Registered office

Roodborstjesstraat 163
9032 Gent · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/03/2025

Average workforce

1,3 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	96,6 k €	-24.7%	128,2 k €	-0.2%	128,4 k €	+12.0%	114,7 k €	+15.4%	99,4 k €	-4.4%	103,9 k €	+21.4%	85,6 k €	-3.0%	88,2 k €	-2.4%	90,4 k €	-7.4%	97,6 k €	+25.7%	77,7 k €	-15.8%	92,3 k €	-16.2%	110,1 k €	+13.4%	97,1 k €	+1.8%	95,3 k €	+3.4%	92,2 k €	+23.9%	74,4 k €	+3.0%	72,2 k €	-25.5%	96,9 k €
EBITDA	22,1 k €	-62.2%	58,5 k €	-20.1%	73,2 k €	+10.5%	66,2 k €	+41.8%	46,7 k €	-10.3%	52 k €	+34.8%	38,6 k €	+3.2%	37,4 k €	-0.3%	37,5 k €	-55.0%	83,5 k €	+667%	10,9 k €	-62.6%	29,1 k €	-41.4%	49,6 k €	+89.0%	26,2 k €	-12.7%	30,1 k €	+127%	13,3 k €	-31.5%	19,4 k €	-8.1%	21,1 k €	-50.8%	42,8 k €
Operating result	4,7 k €	-87.7%	37,9 k €	-24.9%	50,5 k €	+6.3%	47,5 k €	+70.8%	27,8 k €	-2.2%	28,4 k €	+47.3%	19,3 k €	+12.8%	17,1 k €	-1.0%	17,3 k €	-72.5%	63 k €	+570%	9,4 k €	-65.9%	27,6 k €	-44.4%	49,6 k €	+89.0%	26,2 k €	-12.7%	30,1 k €	+129%	13,1 k €	-24.7%	17,5 k €	+61.8%	10,8 k €	-65.2%	31 k €
Net result	11,1 k €	-64.5%	31,2 k €	-18.9%	38,5 k €	-1.6%	39,1 k €	+49.5%	26,2 k €	-0.0%	26,2 k €	+43.0%	18,3 k €	-31.9%	26,9 k €	+28.5%	20,9 k €	-62.0%	55 k €	+327%	12,9 k €	-85.1%	86,5 k €	+148%	34,8 k €	+84.6%	18,8 k €	-0.9%	19 k €	+114%	8,9 k €	+1.5%	8,7 k €	+17.4%	7,5 k €	-33.7%	11,2 k €
Balance sheet
Equity	529 k €	+2.1%	517,9 k €	+3.7%	499,5 k €	+8.4%	461 k €	+9.3%	421,9 k €	+6.6%	395,7 k €	+7.1%	369,5 k €	+5.2%	351,2 k €	+8.3%	324,4 k €	+5.2%	308,4 k €	+17.1%	263,5 k €	+5.1%	250,6 k €	+52.7%	164,1 k €	+26.9%	129,3 k €	+17.1%	110,5 k €	+20.8%	91,5 k €	+10.8%	82,6 k €	+11.8%	73,8 k €	+11.2%	66,4 k €
Total assets	641,4 k €	-3.3%	663 k €	-9.2%	730,2 k €	+14.9%	635,5 k €	+8.3%	586,7 k €	+1.7%	577 k €	+5.6%	546,2 k €	-7.6%	590,9 k €	+7.9%	547,7 k €	-3.3%	566,6 k €	+55.1%	365,4 k €	+10.1%	331,9 k €	+23.3%	269,2 k €	+20.7%	223,1 k €	+11.7%	199,7 k €	+20.6%	165,6 k €	-39.6%	274,4 k €	-4.4%	287,2 k €	-20.3%	360,4 k €
Cash	184,9 k €	+7.6%	171,8 k €	-5.4%	181,6 k €	-29.9%	259,2 k €	+22.1%	212,3 k €	+42.1%	149,3 k €	+48.3%	100,7 k €	+19.7%	84,1 k €	+45.8%	57,7 k €	-17.5%	70 k €	-1.9%	71,3 k €	-14.1%	83 k €	-51.8%	172,3 k €	+70.3%	101,2 k €	+46.0%	69,3 k €	+8.9%	63,6 k €	-8.1%	69,3 k €	+3.1%	67,2 k €	+73.6%	38,7 k €
Debts	97,9 k €	-25.0%	130,6 k €	-39.6%	216,1 k €	+35.1%	160 k €	+6.5%	150,3 k €	-9.6%	166,3 k €	+2.9%	161,7 k €	-26.7%	220,7 k €	+6.4%	207,4 k €	-16.6%	248,8 k €	+363%	53,7 k €	+12.4%	47,8 k €	-39.9%	79,5 k €	+16.1%	68,5 k €	-9.8%	76 k €	+7.6%	70,6 k €	-62.5%	188,2 k €	-10.2%	209,7 k €	-27.4%	288,8 k €
Other
Workforce	1,3 ETP	+18.2%	1,1 ETP	+57.1%	0,7 ETP	0.0%	0,7 ETP	-50.0%	1,4 ETP	+40.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP		–		1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	-16.7%	1,2 ETP	+9.1%	1,1 ETP	+10.0%	1,0 ETP	0.0%	1,0 ETP	-9.1%	1,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 20 ended

Active mandates

CORUM PHARMA

Mandate · 0763.652.492

Represented by Laurence Vanneste

Active

ISALA

Mandate · 0449.855.316

Represented by Isabelle Boone

Active

Ended mandates

CORUM PHARMA

Director · since 01 mars 2021 · until 28 février 2027 · 0763.652.492

Represented by Vanneste LAURENCE

Ended

ISALA

Managing director · since 01 mars 2021 · until 28 février 2027 · 0449.855.316

Represented by Boone ISABELLE

Ended

Axelle Vanneste

Director · since 01 mai 2020 · until 31 août 2024

Ended

Alain Vanneste

Director · since 26 août 2018 · until 30 avril 2020

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/04/2024	01/03/2023	01/03/2022	01/03/2021	01/03/2020	01/03/2019
Closing of the financial year	31/03/2025	31/03/2024	28/02/2023	28/02/2022	28/02/2021	29/02/2020
Length of the financial year	12 months	13 months	12 months	12 months	12 months	12 months
Filing date	31/10/2025	28/10/2024	30/10/2023	07/02/2023	03/03/2022	30/11/2020
General meeting	27/09/2025	28/09/2024	26/08/2023	28/01/2023	31/08/2021	31/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/03/2025	27/09/2025	31/10/2025	Dutch	PDF
Abridged model	31/03/2024	28/09/2024	28/10/2024	Dutch	PDF
Abridged model	28/02/2023	26/08/2023	30/10/2023	Dutch	PDF
Abridged model	28/02/2022	28/01/2023	07/02/2023	Dutch	PDF
Abridged model	28/02/2021	31/08/2021	03/03/2022	Dutch	PDF
Abridged model	29/02/2020	31/08/2020	30/11/2020	Dutch	PDF
Abridged model	28/02/2019	31/08/2019	14/10/2019	Dutch	PDF
Abridged model	28/02/2018	30/08/2018	29/09/2018	Dutch	PDF
Micro model	28/02/2017	26/08/2017	25/09/2017	Dutch	PDF
Abridged model	29/02/2016	27/08/2016	20/09/2016	Dutch	PDF
Abridged model	28/02/2015	29/08/2015	29/09/2015	Dutch	PDF
Abridged model	28/02/2014	30/08/2014	25/09/2014	Dutch	PDF
Abridged model	28/02/2013	31/08/2013	24/09/2013	Dutch	PDF
Abridged model	29/02/2012	31/08/2012	28/09/2012	Dutch	PDF
Abridged model	28/02/2011	31/08/2011	29/09/2011	Dutch	PDF
Abridged model	28/02/2010	28/08/2010	28/09/2010	Dutch	PDF
Abridged model	28/02/2009	29/08/2009	01/10/2009	Dutch	PDF
Abridged model	28/02/2008	23/08/2008	23/09/2008	Dutch	PDF
Abridged model	28/02/2007	25/08/2007	28/09/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 2 active · 20 ended

Active mandates

CORUM PHARMA

Mandate · 0763.652.492

Represented by Laurence Vanneste

Active

ISALA

Mandate · 0449.855.316

Represented by Isabelle Boone

Active

Ended mandates

CORUM PHARMA

Director · since 01 mars 2021 · until 28 février 2027 · 0763.652.492

Represented by Vanneste LAURENCE

Ended

ISALA

Managing director · since 01 mars 2021 · until 28 février 2027 · 0449.855.316

Represented by Boone ISABELLE

Ended

Axelle Vanneste

Director · since 01 mai 2020 · until 31 août 2024

Ended

Alain Vanneste

Director · since 26 août 2018 · until 30 avril 2020

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/05/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates22/09/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/12/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/04/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/11/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/04/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/10/2006
ONTSLAGEN - BENOEMINGEN
PDF
Mandates26/11/2004
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202511,1 k €↓
2024
Annual accounts 202431,2 k €↓
2023
Annual accounts 202338,5 k €↓
2022
Annual accounts 202239,1 k €↑
2021
Annual accounts 202126,2 k €↓
2020
Annual accounts 202026,2 k €↑
2019
Annual accounts 201918,3 k €↓
2018
Annual accounts 201826,9 k €↑
2017
Annual accounts 201720,9 k €↓
2016
Annual accounts 201655 k €↑
2015
Annual accounts 201512,9 k €↓
2014
Annual accounts 201486,5 k €↑
2013
Annual accounts 201334,8 k €↑
2012
Annual accounts 201218,8 k €↓
2011
Annual accounts 201119 k €↑
2010
Annual accounts 20108,9 k €↑
2009
Annual accounts 20098,7 k €↑
2008
Annual accounts 20087,5 k €↓
2007
Annual accounts 200711,2 k €
09/02/1990
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CORUM

Overview

What does CORUM do?

Trend over 19 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline